Forget about fashion aesthetics and the squishy parameters of “fitness goals.” Today Philips enters the U.S. connected health market with five new gadgets, and while the devices aren’t particularly innovative—or even pretty—they do have one feature that less trend-conscious consumers
res of Sarepta Therapeutics nearly halved on Thursday after the meals and Drug management maintained its “poor” outlook on the employer‘s drug for an extraordinary muscle-wasting ailment. Sarepta stock closed down more than forty four percentage. Sarepta is seeking out